Skip to content
Clinical Trials – home
Therapeutic area

Congenital, familial and genetic disorders – page 63

  • 796 clinical trials
  • 308 recruiting
  • 374 conditions
  • 27 countries

Conditions in this area

374 conditions with trials, the busiest first

Clinical trials in Congenital, familial and genetic disorders

796 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

796 clinical trials

Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Miransertib
  • Sponsor:Merck Sharp & Dohme LLC
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years
  • Substances:Theophylline
  • Sponsor:Oslo University Hospital HF
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Edg-5506
  • Sponsor:Edgewise Therapeutics Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Migalastat
  • Sponsor:Amicus Therapeutics Inc.
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Edg-5506
  • Sponsor:Edgewise Therapeutics Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Avalotcagene Ontaparvovec
  • Sponsor:Ultragenyx Pharmaceutical Inc.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Risdiplam
  • Sponsor:UZ Leuven

Prader-Willi syndrome

Not recruiting
Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Pbf-999
  • Sponsor:Palo Biofarma S.L.

Hereditary ataxia

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Trehalose Dihydrate (Ph.eur.)
  • Sponsor:Seelos Therapeutics Inc.
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Famotidine
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Autologous Cd34+ Hematopoietic Stem Cells Transduced Ex Vivo With A Lentiviral Vector Encoding The Codon-Optimized Version Of Pklr Gene
  • Sponsor:Rocket Pharmaceuticals Inc.

Substances studied in this area

The therapies tested most often in Congenital, familial and genetic disorders trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.